Checkpoint inhibitors synergize with therapeutic platforms, ZVex™ and GLAAS™ by enhancing lentiviral vector-induced tumor-specific immunity and adjuvant-mediated anti-tumor efficacy

Detalles Bibliográficos
Autores principales: Albershardt, Tina C, Parsons, Andrea J, ter Meulen, Jan, Berglund, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649483/
http://dx.doi.org/10.1186/2051-1426-3-S2-P346
Descripción
Sumario:

Ejemplares similares